Facilitated Myocardial Ablation Using Heat-Sensitive Liposomes Containing Doxorubicin: A Proof-of-Concept Preclinical Study

JACC Clin Electrophysiol. 2023 Aug;9(8 Pt 1):1404-1408. doi: 10.1016/j.jacep.2023.02.025. Epub 2023 May 24.

Abstract

The authors sought to evaluate a method for improving radiofrequency (RF) lesion durability using doxorubicin encased in heat-sensitive liposomes (HSL-dox). Using a porcine model, RF ablations were performed in the right atrium after systemic infusion of either HSL-dox or saline control given immediately before mapping and ablation. Lesion geometry was measured with voltage mapping immediately postablation and after 2 weeks of survival. After 2 weeks, lesions demonstrated less regression in scar area in HSL-dox-exposed animals compared with control animals. We demonstrate improved RF lesion durability in animals treated with HSL-dox, and the cardiotoxic effect was more pronounced after RF applications with higher power and longer duration.

Keywords: ablation; pharmacokinetics; ventricular arrhythmias.

Publication types

  • Review

MeSH terms

  • Animals
  • Doxorubicin / therapeutic use
  • Heart Atria
  • Hot Temperature*
  • Liposomes*
  • Myocardium
  • Swine

Substances

  • Liposomes
  • Doxorubicin